Redirection to the bone marrow improves T cell persistence and antitumor functions.
Saved in:
| Title: | Redirection to the bone marrow improves T cell persistence and antitumor functions. |
|---|---|
| Authors: | Khan AB; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Carpenter B; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Santos E Sousa P; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Pospori C; Department of Life Sciences, Imperial College London, London, United Kingdom., Khorshed R; Department of Life Sciences, Imperial College London, London, United Kingdom., Griffin J; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Velica P; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Zech M; UCL Institute of Immunity and Transplantation, London, United Kingdom., Ghorashian S; UCL Institute of Immunity and Transplantation, London, United Kingdom., Forrest C; University College London (UCL) Cancer Institute, London, United Kingdom., Thomas S; UCL Institute of Immunity and Transplantation, London, United Kingdom., Gonzalez Anton S; Department of Life Sciences, Imperial College London, London, United Kingdom., Ahmadi M; UCL Institute of Immunity and Transplantation, London, United Kingdom., Holler A; UCL Institute of Immunity and Transplantation, London, United Kingdom., Flutter B; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Ramirez-Ortiz Z; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts, USA., Means TK; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts, USA., Bennett CL; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom., Stauss H; UCL Institute of Immunity and Transplantation, London, United Kingdom., Morris E; UCL Institute of Immunity and Transplantation, London, United Kingdom., Lo Celso C; Department of Life Sciences, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom., Chakraverty R; University College London (UCL) Cancer Institute, London, United Kingdom.; UCL Institute of Immunity and Transplantation, London, United Kingdom. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2018 May 01; Vol. 128 (5), pp. 2010-2024. Date of Electronic Publication: 2018 Apr 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
